No Detail Found!

Patterns of Bone Metastases in Cancer Patients Referred for Bone Scintigraphy in the Hail Region: A Retrospective Cross-Sectional Study

Author(s)
Amirah Fahad Alshammeri Department of Radiology, College of Medicine, University of Hail, 5211, Saudi Arabia
Aldanah Yahya Alkhaled Department of Medicine and Surgery, College of Medicine, University of Hail, 5211, Saudi Arabia
Basmah Mousa Alharbi Department of Medicine and Surgery, College of Medicine, University of Hail, 5211, Saudi Arabia
Hajer Saleh Alshammari Department of Medicine and Surgery, College of Medicine, University of Hail, 5211, Saudi Arabia
Noha Mousa Alharbi Department of Medicine and Surgery, College of Medicine, University of Hail, 5211, Saudi Arabia
Rahaf Hamed Alrashedi Department of Medicine and Surgery, College of Medicine, University of Hail, 5211, Saudi Arabia
Shahad Abdulaziz Alafnan Department of Medicine and Surgery, College of Medicine, University of Hail, 5211, Saudi Arabia
Abdulrahim Saud Alazmi Department of Radiology, Nuclear Medicine Unit, Saudi Arabia
Abdullah Awad Alharbi Department of Radiology, Nuclear Medicine Unit, Saudi Arabia
Bandar Matar Alselmi Department of Nuclear Medicine, King Khalid Hospital, Hail Health Cluster, Saudi Arabia
Fahmida Khatoon Department of Biochemistry, College Of Medicine, University of Ha’il, Saudi Arabia
Abstract
Background: Bone metastases are a common complication of advanced malignancies. Data on their patterns in northern Saudi Arabia are scarce. Objective: To characterize the prevalence, anatomical distribution and scintigraphic image of bone metastases of cancer patients undergoing SPECT/CT bone scan in the Hail region. Methods: Retrospective evaluation of patients with solid tumors (adults) who received Tc-99m MDP whole-body SPECT/CT bone scintigraphy at King Khalid General Hospital between January 2020 and December 2024 (n = 222). Demographic, clinical and imaging data were analyzed using descriptive statistics and the chi-square test, while multivariate logistic regression was performed to identify independent associations with bone metastasis. Results: Breast cancer was the highest primary tumor (71.6%) followed by prostate (9.9%). Definite bone metastases were detected in 23.4% of the patients and 63.5% had no involvement of the skeleton. Among the patients with abnormal scans, multiple lesions (2-10) were the predominant pattern (24.8% of all patients), with the lumbar spine (70.0%), ribs (64.3%), thoracic spine (57.1%) and pelvis (57.1%) being the predominant sites of involvement. Suspected as benign uptake was recorded in 65.3% of patients mainly caused by degenerative changes. In multivariate analysis, age, gender and type of primary tumor and pathological fracture were not independent risk factors for bone metastasis. Conclusion: In this regional cohort population there was a predominance of metastatic bone tumors to the axial skeletal system with breast cancer and prostate cancer being the predominant tumor in group observed. Bone scintigraphy with SPECT/CT is a useful screening tool for potential whole-body diseases, however, the high rate of uptake classified as most likely benign makes it critical to provide careful clinical correlation and more specific use of other imaging modalities.
Publication Details
Page(s) 121-130
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 2, Year: 2026

Request the full text from PASTIC

Keywords
Skeletal Imaging, Bone scintigraphy, Saudi Arabia, Cancer epidemiology, Hail Region, Bone metastases, Technetium-99m
References
Huang J.F. .2020 .Incidence of patients with bone metastases at diagnosis of solid tumors in adults: A Large PopulationBased Study. Annals of Translational Medicine, 03(2020) : 482.
Clézardin P. .2019 .Bone metastasis: mechanisms, therapies and biomarkers. Physiological Reviews, 101(2021) : 797-855.
Elaasser B. . .Bridging the gap in understanding bone metastasis: A multifaceted perspective. International Journal of Molecular Sciences, 25(2024) : 2846.
Othman A. .2021 .Bone metastatic breast cancer: Advances in cell signaling and autophagy related mechanisms. ” Cancers, 13(17) : 4310.
Baldessari C. . .Bone metastases and health in prostate cancer: From pathophysiology to clinical implications. ” Cancers, 15(2023) : 1518.
Arakil N. . .Intersecting paths: Unraveling the complex journey of cancer to bone metastasis. ” Biomedicines, 12(2024) : 1075.
Ban J. .2021 .Mechanisms, diagnosis and treatment of bone metastases. ” Cells, 10(11) : 2944.
Ouvrard E. .2023 .Nuclear medicine imaging for bone metastases assessment: What Else besides bone scintigraphy in the era of personalized medicine?” Frontiers in Medicine. , 1320574 : 1320574.
Mohseninia N. .2023 .Bone metastasis in prostate cancer: Bone scan versus PET imaging.” Seminars in Nuclear Medicine. , 07(2024) : 97-118.
De Bondt C. .1907 .A Flare for the unexpected: Bone flare as response to tyrosine kinase inhibitor treatment in a lung cancer patient. ” Journal of the Belgian Society of Radiology, 104(2020) : 18.
Isaac A. . .State-of-the-art imaging for diagnosis of metastatic bone disease. ” Der Radiologe, 60(2020) : 1-6.
Bray F. .2022 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(2024) : 229-263.
Hsieh T.C. .2021 .detection of bone metastases on bone scans through image classification with contrastive learning. ” Journal of Personalized Medicine, 11(12) : 1248.
Khatoon F. . .Genetic insights into β-Cell dysfunction and obesity: Unveiling their role in type 2 diabetes risk among the Saudi Arabian population with clinical implications. ” Journal of Pioneering Medical Sciences, 14(2025) : 122-129.
Khtoon F. . .Environmental and genetic influences on placental morphogenesis: Integrating maternal health and fetal outcomes. ” Journal of Pioneering Medical Sciences, 14(2025) : 156-163.
Ishibashi N. . .Bone scan index on bone scintigraphy and radiation therapy for bone metastases from cancers other than prostate and breast cancers: A retrospective observational study. ” Journal of Cancer Research and Therapeutics, 1558(2022) : 20-1721.
Yousef M. .2024 .Bone metastasis evaluation using bone scintigraphy. ” Medicine and Biohealth Journal, 1(1) : .
Santos Cristo,J. Cristo . .Bone metastases detection in patients with breast cancer: Does bone scintigraphy add information to PET/CT?” The Oncologist. , 28(2023) : e600-e605.
Bruckmann N.M. .2021 .Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. ” European Radiology, 31(11) : 8714-8724.
0

Citations

0

Downloads

16

Views